摘要
目的探讨新型冠状病毒肺炎(COVID-19)专科医院在药品使用和保障方面的特点,总结经验和不足。为今后快速精准完成类似任务保障提供借鉴。方法回顾分析2020年2月3日火神山医院正式收治患者后前3周的药品使用情况,并对用药频度进行对比。结果该院前3周的药品使用频度排名前5位的分别是连花清瘟胶囊、静注人免疫球蛋白、硝苯地平缓释片、阿比多尔片和阿司匹林肠溶片。结论COVID-19疫情来势凶猛,临床治疗以多种抗病毒方法并辅以对症处理为主要手段。在临床实践中通过不断尝试抗病毒、抗菌治疗以及调节免疫等方法,形成比较固定的方案,最终达到降低病死率的目标。
Objective To explore the characteristics of drug use and drug supply in hospitals for corona virus disease 2019(COVID-19),and summarize the experience and flaws in order to provides reference for similar tasks in future.Methods The quantity and the frequency of medication in the first three weeks after the hospital officially admitted patients on 3 rd February was analyzed retrospectively.Results In the first three weeks,the top five drugs in terms of DDDs were Lianhua Qingwen capsules,intravenous injection of human immunoglobulin,nifedipine sustained-release tablets,arbidol tablets and aspirin enteric coated tablets.Conclusion The outbreak of COVID-19 is devastating,so clinical treatment depends on a variety of antiviral methods and complementary symptomatic treatment.In clinical practice,constant trial of anti-viral and anti-bacterial treatment and immune regulation will finally end up with a relatively fixed program that helps achieve the goal of reducing the fatality rate.
作者
施金虎
李治
姜舒
袁力
杨晨
党大胜
张强
王萍
刘翠英
樊磊
吴红海
李文斌
梁泉
蔡军
刘晓凯
李骁
魏穷
马晨骁
季波
徐晓莉
SHI Jin⁃hu;LI Zhi;JIANG Shu;YUAN Li;YANG Chen;DANG DA⁃sheng;ZHANG Qiang;WANG Ping;LIU Cui⁃ying;FAN Lei;WU Hong⁃hai;LI Wen⁃bin;LIANG Quan;CAI Jun;LIU Xiao⁃kai;LI Xiao;WEI Qiong;MA Chen⁃xiao;JI Bo;XU Xiao⁃Li(General Hospital of Eastern Theater Command of PLA,Nangjing 210002,China;Wuhan Huoshenshan Hospital,Wu⁃han 430100,China)
出处
《军事医学》
CAS
北大核心
2020年第4期296-299,共4页
Military Medical Sciences
基金
军队后勤科研面上项目(CLB19L026,CWH17R032)
军队医药卫生成果扩试计划项目(19WKS04)
